213 related articles for article (PubMed ID: 19491025)
1. Biopharmaceutic and pharmacodynamic modeling of the in vitro antiproliferative effect of new controlled delivery systems of cisplatin.
Moreno D; Zalba S; Colom H; Trocóniz IF; Tros de Ilarduya C; Garrido MJ
Eur J Pharm Sci; 2009 Jun; 37(3-4):341-50. PubMed ID: 19491025
[TBL] [Abstract][Full Text] [Related]
2. Characterization of cisplatin cytotoxicity delivered from PLGA-systems.
Moreno D; de Ilarduya CT; Bandrés E; Buñuales M; Azcona M; García-Foncillas J; Garrido MJ
Eur J Pharm Biopharm; 2008 Mar; 68(3):503-12. PubMed ID: 17881198
[TBL] [Abstract][Full Text] [Related]
3. Semi-mechanistic description of the in-vitro antiproliferative effect of different antitumour agents.
Moreno D; Trocóniz IF; Enguita M; Bandrés E; García-Foncillas J; Garrido MJ
J Pharm Pharmacol; 2008 Jan; 60(1):77-82. PubMed ID: 18088508
[TBL] [Abstract][Full Text] [Related]
4. Pharmacodynamics of cisplatin-loaded PLGA nanoparticles administered to tumor-bearing mice.
Moreno D; Zalba S; Navarro I; Tros de Ilarduya C; Garrido MJ
Eur J Pharm Biopharm; 2010 Feb; 74(2):265-74. PubMed ID: 19883755
[TBL] [Abstract][Full Text] [Related]
5. Biodegradable microparticles and fiber fabrics for sustained delivery of cisplatin to treat C6 glioma in vitro.
Xie J; Tan RS; Wang CH
J Biomed Mater Res A; 2008 Jun; 85(4):897-908. PubMed ID: 17896769
[TBL] [Abstract][Full Text] [Related]
6. PLGA-based drug delivery systems: importance of the type of drug and device geometry.
Klose D; Siepmann F; Elkharraz K; Siepmann J
Int J Pharm; 2008 Apr; 354(1-2):95-103. PubMed ID: 18055140
[TBL] [Abstract][Full Text] [Related]
7. Superior antitumor efficiency of cisplatin-loaded nanoparticles by intratumoral delivery with decreased tumor metabolism rate.
Li X; Li R; Qian X; Ding Y; Tu Y; Guo R; Hu Y; Jiang X; Guo W; Liu B
Eur J Pharm Biopharm; 2008 Nov; 70(3):726-34. PubMed ID: 18634874
[TBL] [Abstract][Full Text] [Related]
8. Controlled delivery of aspirin: effect of aspirin on polymer degradation and in vitro release from PLGA based phase sensitive systems.
Tang Y; Singh J
Int J Pharm; 2008 Jun; 357(1-2):119-25. PubMed ID: 18329202
[TBL] [Abstract][Full Text] [Related]
9. Cisplatin/hydrogel complex in cancer therapy.
Casolaro M; Cini R; Del Bello B; Ferrali M; Maellaro E
Biomacromolecules; 2009 Apr; 10(4):944-9. PubMed ID: 19254026
[TBL] [Abstract][Full Text] [Related]
10. Interactions of cisplatin with calcium phosphate nanoparticles: in vitro controlled adsorption and release.
Barroug A; Kuhn LT; Gerstenfeld LC; Glimcher MJ
J Orthop Res; 2004 Jul; 22(4):703-8. PubMed ID: 15183424
[TBL] [Abstract][Full Text] [Related]
11. Anticancer activity of cisplatin-loaded PLGA-mPEG nanoparticles on LNCaP prostate cancer cells.
Gryparis EC; Hatziapostolou M; Papadimitriou E; Avgoustakis K
Eur J Pharm Biopharm; 2007 Aug; 67(1):1-8. PubMed ID: 17303395
[TBL] [Abstract][Full Text] [Related]
12. Anti-tumor activity of the TRA-8 anti-DR5 antibody in combination with cisplatin in an ex vivo human cervical cancer model.
Kendrick JE; Straughn JM; Oliver PG; Wang W; Nan L; Grizzle WE; Stockard CR; Alvarez RD; Buchsbaum DJ
Gynecol Oncol; 2008 Mar; 108(3):591-7. PubMed ID: 18177927
[TBL] [Abstract][Full Text] [Related]
13. Enhancement of the stability of BCNU using self-emulsifying drug delivery systems (SEDDS) and in vitro antitumor activity of self-emulsified BCNU-loaded PLGA wafer.
Chae GS; Lee JS; Kim SH; Seo KS; Kim MS; Lee HB; Khang G
Int J Pharm; 2005 Sep; 301(1-2):6-14. PubMed ID: 16024190
[TBL] [Abstract][Full Text] [Related]
14. Interactions of doxycycline with chemotherapeutic agents in human breast adenocarcinoma MDA-MB-231 cells.
Foroodi F; Duivenvoorden WC; Singh G
Anticancer Drugs; 2009 Feb; 20(2):115-22. PubMed ID: 19209028
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of in vitro and in vivo antitumor activity of BCNU-loaded PLGA wafer against 9L gliosarcoma.
Lee JS; An TK; Chae GS; Jeong JK; Cho SH; Lee HB; Khang G
Eur J Pharm Biopharm; 2005 Jan; 59(1):169-75. PubMed ID: 15567315
[TBL] [Abstract][Full Text] [Related]
16. Cisplatin encapsulated in phosphatidylethanolamine liposomes enhances the in vitro cytotoxicity and in vivo intratumor drug accumulation against melanomas.
Hwang TL; Lee WR; Hua SC; Fang JY
J Dermatol Sci; 2007 Apr; 46(1):11-20. PubMed ID: 17267180
[TBL] [Abstract][Full Text] [Related]
17. Star-shaped nano-conjugates of cisplatin with high drug payload.
Kowalczuk A; Stoyanova E; Mitova V; Shestakova P; Momekov G; Momekova D; Koseva N
Int J Pharm; 2011 Feb; 404(1-2):220-30. PubMed ID: 21078377
[TBL] [Abstract][Full Text] [Related]
18. In-vitro evaluation of paclitaxel-loaded MPEG-PLGA nanoparticles on laryngeal cancer cells.
Gao C; Pan J; Lu W; Zhang M; Zhou L; Tian J
Anticancer Drugs; 2009 Oct; 20(9):807-14. PubMed ID: 19696655
[TBL] [Abstract][Full Text] [Related]
19. Formulation, characterization and evaluation of curcumin-loaded PLGA nanospheres for cancer therapy.
Mukerjee A; Vishwanatha JK
Anticancer Res; 2009 Oct; 29(10):3867-75. PubMed ID: 19846921
[TBL] [Abstract][Full Text] [Related]
20. Composite fiber structures with antiproliferative agents exhibit advantageous drug delivery and cell growth inhibition in vitro.
Kraitzer A; Kloog Y; Haklai R; Zilberman M
J Pharm Sci; 2011 Jan; 100(1):133-49. PubMed ID: 20623695
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
